Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Theseus Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +1 vs. Q4 2021
- Shares held
- 35.0M
- +123.7K (+0.4%) vs. Q4 2021
- Total value
- $402.8M
- −$38.6M (−8.7%) vs. Q4 2021
- New holders
- 5
- 12 more added
- Sold out
- 4
- 15 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 70 | $145.8M |
| Q3 2023 | 63 | $95.5M |
| Q2 2023 | 69 | $373.6M |
| Q1 2023 | 72 | $350.6M |
| Q4 2022 | 47 | $164.8M |
| Q3 2022 | 51 | $200.7M |
| Q2 2022 | 51 | $191.6M |
| Q1 2022 | 47 | $402.8M |
| Q4 2021 | 46 | $441.4M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Theseus Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 449 | $5.00K | 0.00% | −2,698−85.7% | Reduced |
| Royal Bank of Canada | 707 | $8.00K | 0.00% | −1,575−69.0% | Reduced |
| Ameritas Investment Partners, Inc. | 889 | $10.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,059 | $12.0K | 0.00% | 00.0% | Unchanged |
| High Net Worth Advisory Group LLC | 1,300 | $15.0K | 0.01% | +1,300 | New |
| Tower Research Capital LLC (TRC) | 1,408 | $16.0K | 0.00% | −712−33.6% | Reduced |
| Amalgamated Bank | 1,670 | $19.0K | 0.00% | +1,670 | New |
| Amalgamated Financial Corp. | 1,670 | $19.0K | 0.00% | +1,670 | New |
| UBS Group AG | 2,041 | $24.0K | 0.00% | −1,527−42.8% | Reduced |
| Wells Fargo & Company | 2,499 | $29.0K | 0.00% | −4,275−63.1% | Reduced |
| STRS Ohio | 2,700 | $31.0K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 4,926 | $57.0K | 0.00% | −1,399−22.1% | Reduced |
| Bank of America Corp | 5,074 | $59.0K | 0.00% | −2,832−35.8% | Reduced |
| JPMorgan Chase & Co | 5,397 | $62.0K | 0.00% | +289+5.7% | Added |
| American International Group, Inc. | 5,714 | $66.0K | 0.00% | −402−6.6% | Reduced |
| Deutsche Bank AG | 6,253 | $72.0K | 0.00% | −740−10.6% | Reduced |
| Barclays PLC | 6,210 | $72.0K | 0.00% | +6,210 | New |
| New York State Common Retirement Fund | 9,495 | $109.0K | 0.00% | +7,844+475.1% | Added |
| Morgan Stanley | 9,648 | $111.0K | 0.00% | −31−0.3% | Reduced |
| Nuveen Asset Management, LLC | 17,494 | $202.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 29,379 | $338.0K | 0.00% | +12,219+71.2% | Added |
| Charles Schwab Investment Management Inc | 32,229 | $372.0K | 0.00% | +1,285+4.2% | Added |
| Manufacturers Life Insurance Company, The | 59,923 | $701.3K | 0.00% | +59,923 | New |
| TD Asset Management Inc | 67,133 | $774.0K | 0.00% | +10,931+19.4% | Added |
| DAFNA Capital Management LLC | 80,124 | $924.0K | 0.24% | −17,376−17.8% | Reduced |
| Northern Trust Corp | 97,139 | $1.12M | 0.00% | +255+0.3% | Added |
| Tekla Capital Management LLC | 100,000 | $1.15M | 0.04% | 00.0% | Unchanged |
| Laurion Capital Management LP | 179,619 | $2.07M | 0.05% | −25,402−12.4% | Reduced |
| State Street Corp | 182,661 | $2.11M | 0.00% | +55,865+44.1% | Added |
| Geode Capital Management, LLC | 202,436 | $2.33M | 0.00% | +10,389+5.4% | Added |
| Ensign Peak Advisors, Inc | 250,000 | $2.88M | 0.01% | 00.0% | Unchanged |
| Woodline Partners LP | 250,000 | $2.88M | 0.05% | 00.0% | Unchanged |
| Wellington Management Group LLP | 293,587 | $3.38M | 0.00% | −331,233−53.0% | Reduced |
| Lynx1 Capital Management LP | 356,827 | $4.11M | 3.82% | −52,531−12.8% | Reduced |
| Rock Springs Capital Management LP | 437,329 | $5.04M | 0.13% | 00.0% | Unchanged |
| Foresite Capital Opportunity Management V, LLC | 468,820 | $5.41M | 7.57% | 00.0% | Unchanged |
| Vanguard Group Inc | 486,362 | $5.61M | 0.00% | −396−0.1% | Reduced |
| Farallon Capital Management, L.L.C. | 523,979 | $6.04M | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 544,855 | $6.28M | 0.00% | +11,592+2.2% | Added |
| Nextech Invest AG | 611,310 | $7.05M | 2.01% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 711,479 | $8.20M | 1.68% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 761,589 | $8.78M | 0.02% | 00.0% | Unchanged |
| Boxer Capital, LLC | 892,057 | $10.3M | 0.53% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,436,616 | $16.3M | 0.00% | +137,129+10.6% | Added |
| Foresite Capital Management V, LLC | 3,212,732 | $37.0M | 15.13% | 00.0% | Unchanged |
| FMR LLC | 5,557,447 | $64.1M | 0.01% | +108,778+2.0% | Added |
| OrbiMed Advisors LLC | 17,041,668 | $196.5M | 3.19% | +203,000+1.2% | Added |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −22,136−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −11,340−100.0% | Sold out |